Testosterone Injury Lawsuits Approach 2,000 Mark
The number of product liability complaints regarding testosterone replacement therapy continues to skyrocket, with allegations that the products caused heart attacks, stroke, and debilitating blood...
View ArticleLawsuit Alleges AndroGel Use Caused Multiple Strokes
On August 13, 2015, two New York residents filed an AndroGel lawsuit, alleging that the drug caused a stroke on multiple occasions. The plaintiffs, Denis Sitruk and Suzanne Sitruk, have added their...
View ArticleDoes Testosterone Therapy Contribute to Atherosclerosis?
The use of testosterone replacement therapy (TRT) has been increasing, yet some have expressed concerns about potentially life-threatening side effects of testosterone gels, creams, patches, and other...
View ArticleFDA Researchers Express Concerns About Testosterone Therapy
In the August 20, 2015 issue of the New England Journal of Medicine, FDA researchers published an article that expressed their concerns regarding testosterone therapy side effects. Specifically, they...
View ArticleStudy Examines Testosterone Dosage and Heart Risks
In July, researchers from the University of North Carolina at Chapel Hill published a study on testosterone heart risks in the medical journal, JAMA Internal Medicine, finding that the side effects of...
View ArticleCouple Files Lawsuit Alleging Severe Complications with Androgel
On September 30, 2015, a husband and wife filed their complaint in the ongoing Testosterone Replacement Therapy Products multidistrict Litigation (MDL) against drug makers including AbbVie, Eli Lilly,...
View ArticleTestosterone Lawsuit Alleges Hormone Therapy Led to Heart Attack
A plaintiff who filed a lawsuit against multiple manufacturers of testosterone therapy products claims use of Testim and Androgel led to his heart attack in 2013. The plaintiff has joined more than...
View ArticleAndrogel Lawsuits Identified for Bellwether Trial Pool
The first bellwether trials in multidistrict litigation 2545, which concerns injuries allegedly caused by testosterone replacement therapy, are slated to go to trial by fall of 2016.Court dockets show...
View ArticleBellwether Trials for Androgel Litigation Set for 2017
U.S. District Judge Matthew Kennelly of the Northern District of Illinois has issued a schedule of bellwether trials for six Androgel lawsuits. The trials are expected to begin in April and conclude...
View ArticleTestosterone Claim Involving Testim Joins MDL 2545
An Arlington, Texas man has filed a testosterone lawsuit against Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC. His lawsuit will join the multidistrict litigation...
View ArticleEarly Trials Selected for Growing Androgel Lawsuits
Eight Androgel lawsuits have been selected out of around 5,500 cases currently pending to serve as bellwether trials in the coordinated litigation. The bellwether trials are carefully selected to...
View ArticleStudies Cast Doubt on Testosterone Therapy Benefits
Testosterone supplementation for older men has become big business for companies like Abbott Laboratories and AbbVie as they have marketed their testosterone products to the general population....
View ArticleStudy Says Testosterone Replacement Therapy Increases Heart Attack, Stroke...
The conclusions of a significant new clinical trial indicate that testosterone replacement therapy increases the risk of heart attacks and strokes among men receiving it. The treatments include the...
View ArticleAndrogel Bellwether Trial Ruling Favors Plaintiffs
In a case management order filed by US District Judge Matthew F. Kennelly, Androgel maker AbbVie was denied its attempt to have the first bellwether case dismissed on grounds that the statute of...
View ArticleJudge Orders Settlement Talks After Large Jury Verdicts In Androgel Lawsuits
Several very large jury verdicts against the makers of Androgel, AbbVie, caused the U.S. District Judge in charge of Federal multidistrict litigation (MDL) in a number of Androgel trials to order the...
View Article400 Testosterone Therapy Lawsuits Resolved with Global Settlement
Hundreds of plaintiffs and the defendant, Eli Lilly and Company, reached a global settlement agreement that resolves all federally filed Axiron lawsuits pending against the pharmaceutical giant. The...
View Article500 Androderm Lawsuits May Be Resolved Soon
Actavis, the makers of Androderm, has announced that there is a tentative settlement agreement in place that would resolve roughly 500 lawsuits. The plaintiffs involved with the litigation allege that...
View ArticleSettlement Finalized for Androderm Testosterone Lawsuits
Hundreds of testosterone lawsuits have been officially resolved now that the master settlement agreement has been finalized, as of late July 2018. The settlement agreement only applies to Androderm...
View ArticleStudy: Testosterone Therapy Raises the Risk of Blood Clots
There is new, compelling evidence to suggest that all men who use testosterone therapy products have an increased risk of life-threatening blood clots. This remains true regardless of whether the...
View Article
More Pages to Explore .....